Conformis announced that it received a letter from the Listing Qualifications Department of Nasdaq Stock Market notifying Conformis that, based on the closing bid price of Conformis’ common stock having been $1.00 per share or greater on each of the trading days from November 10 to November 23, Conformis has regained compliance with Nasdaq Listing Rule 5550 and the minimum bid price deficiency matter previously disclosed by Conformis is now closed.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CFMS:
- Conformis, Inc. Regains Compliance with Nasdaq’s Minimum Bid Price Rule
- Conformis Announces First Procedure Performed Using New Actera™ Hip System
- Conformis announces first procedure performed using Actera Hip System
- Conformis Announces Full Commercial Launch of Imprint™
- Conformis enters settlement, license agreement with Medacta USA